These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20087032)

  • 1. [Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
    Watanabe K; Otake T; Yasuda M; Takenoshita S
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):51-6. PubMed ID: 20087032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of trastuzumab and vinorelbine in metastatic breast cancer.
    Suzuki Y; Tokuda Y; Saito Y; Ohta M; Tajima T
    Jpn J Clin Oncol; 2003 Oct; 33(10):514-7. PubMed ID: 14623919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A pilot study of trastuzumab and vinorelbine-combined therapy for metastatic breast cancer].
    Onishi I; Tsugawa K; Nakamura M; Nishimura G; Fujimura T; Taniya T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Gan To Kagaku Ryoho; 2004 May; 31(5):743-6. PubMed ID: 15170984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C and vinorelbine in pretreated breast cancer.
    Colleoni M; Manente P; Stocker J; Amor H; Lamon S; Nelli P; Vicario G; Sgarbossa G; Graiff C
    Tumori; 1997; 83(5):834-6. PubMed ID: 9428918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
    Farhat F; Kattan JG; Ghosn M
    Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "A review of vinorelbine in the treatment of breast cancer".
    Ibrahim NK
    Clin Breast Cancer; 2001 Oct; 2(3):236. PubMed ID: 11899419
    [No Abstract]   [Full Text] [Related]  

  • 8. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.
    Chan A; Martin M; Untch M; Gil MG; Guillem-Porta V; Wojtukiewicz M; Kellokumpu-Lehtinen P; Sommer HL; Georgoulias V; Battelli N; Pawlicki M; Aubert D; Bourlard T; Gasmi J; Villanova G; Petruzelka L;
    Br J Cancer; 2006 Oct; 95(7):788-93. PubMed ID: 16969343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of inflammatory carcinoma, well-controlled by chemotherapy, especially, vinorelbine, S-1 and trastuzumab].
    Tanigawa T; Miyamoto Y; Abe M; Hasuo T; Doiguchi M; Sakamoto F
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1515-8. PubMed ID: 19755823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of recurrent breast cancer responding to vinorelbine/trastuzumab combination therapy].
    Fujisawa M; Uomori T; Takehara K; Mitsugi Y; Yoshino K; Okumura M; Machida M; Kitabatake T; Ishibiki Y; Kojima K; Ogura K; Matsumoto T
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2631-5. PubMed ID: 20009469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy.
    Zelnak AB; Nikolinakos P; Srinivasiah J; Jonas W; Pippas A; Liu Y; Li X; Torres M; O'Regan RM;
    Clin Breast Cancer; 2015 Feb; 15(1):31-6. PubMed ID: 25065563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
    Joensuu H; Bono P; Kataja V; Alanko T; Kokko R; Asola R; Utriainen T; Turpeenniemi-Hujanen T; Jyrkkiö S; Möykkynen K; Helle L; Ingalsuo S; Pajunen M; Huusko M; Salminen T; Auvinen P; Leinonen H; Leinonen M; Isola J; Kellokumpu-Lehtinen PL
    J Clin Oncol; 2009 Dec; 27(34):5685-92. PubMed ID: 19884557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.
    De Maio E; Pacilio C; Gravina A; Morabito A; Di Rella F; Labonia V; Landi G; Nuzzo F; Rossi E; Silvestro P; Botti G; Di Bonito M; Curcio MP; Formichelli F; La Vecchia F; Staiano M; Maurea N; D'Aiuto G; D'Aiuto M; Thomas R; Signoriello G; Perrone F; de Matteis A
    BMC Cancer; 2007 Mar; 7():50. PubMed ID: 17374151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
    Burstein HJ; Kuter I; Campos SM; Gelman RS; Tribou L; Parker LM; Manola J; Younger J; Matulonis U; Bunnell CA; Partridge AH; Richardson PG; Clarke K; Shulman LN; Winer EP
    J Clin Oncol; 2001 May; 19(10):2722-30. PubMed ID: 11352965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
    De Placido S; Lauria R; Perrone F; Vernaglia Lombardi A; Carlomagno C; Varriale E; Costanzo R; Leo L; De Laurentiis M; Bianco AR
    Oncology; 2000; 58(1):8-14. PubMed ID: 10644934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving forward with capecitabine: a glimpse of the future.
    Biganzoli L; Martin M; Twelves C
    Oncologist; 2002; 7 Suppl 6():29-35. PubMed ID: 12454317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory breast cancer: a comparison of two different chemotherapy regimens.
    Erkisi M; Bilkay BC; Seyrek E; Hazar B; Burgut R
    J Chemother; 1997 Dec; 9(6):442-5. PubMed ID: 9491846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast cancer: HER2 changes one's cards on the table].
    Lopez M
    Clin Ter; 2005; 156(5):255-62. PubMed ID: 16382976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T; Jagiello-Gruszfeld A
    Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.